Myeloablative BU, fludarabine, antithymocyte globulin and low-dose TBI in the treatment of juvenile myelomonocytic leukaemia with allogeneic haematopoietic cell transplantation

被引：0
|
作者：
G M T Guilcher
R Moorjani
T H Truong
V A Lewis
机构：
[1] University of Calgary,
[2] Section of Haematology/Oncology/Transplant,undefined
[3] Alberta Children’s Hospital,undefined
来源：
Bone Marrow Transplantation | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：455 / 456
页数：1
相关论文
共 50 条
  • [41] Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
    Bryant, Adam
    Mallick, Ranjeeta
    Huebsch, Lothar
    Allan, David
    Atkins, Harold
    Anstee, Grizel
    Sabloff, Mitchell
    Scrivens, Nicholas
    Maze, Dawn
    Bredeson, Chris
    Kekre, Natasha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (12) : 2096 - 2101
  • [42] Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JS']JSTCT
    Fujioka, Machiko
    Itonaga, Hidehiro
    Nakazawa, Hideyuki
    Nishida, Tetsuya
    Kataoka, Keisuke
    Ikeda, Takashi
    Kako, Shinichi
    Matsuoka, Ken-ichi
    Adachi, Koji
    Fujiwara, Shin-ichiro
    Aotsuka, Nobuyuki
    Kawakita, Toshiro
    Sakaida, Emiko
    Kanda, Yoshinobu
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Miyazaki, Yasushi
    Ishiyama, Ken
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (01): : 18e1 - 18e12
  • [43] Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation
    Jabbour, E.
    Rondon, G.
    Anderlini, P.
    Giralt, S. A.
    Couriel, D. R.
    Champlin, R. E.
    Khouri, I. F.
    BONE MARROW TRANSPLANTATION, 2007, 40 (05) : 431 - 435
  • [44] Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation
    E Jabbour
    G Rondon
    P Anderlini
    S A Giralt
    D R Couriel
    R E Champlin
    I F Khouri
    Bone Marrow Transplantation, 2007, 40 : 431 - 435
  • [45] FAVORABLE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA USING FLUDARABINE, CYCLOPHOSPHAMIDE, ATG WITH OR WITHOUT LOW-DOSE TBI
    Kohashi, S.
    Mori, T.
    Kato, J.
    Yamane, A.
    Okamoto, S.
    HAEMATOLOGICA, 2012, 97 : 727 - 727
  • [46] Impact of the use of antithymocyte globulin on cellular immune reconstitution after allogeneic haematopoietic stem cell transplantation
    Bordon, V.
    Dhooge, C.
    Mondelaers, V.
    De Moerloose, B.
    Benoit, Y.
    Laureys, G.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S366 - S366
  • [47] Improved myeloablative conditioning regimen for allogeneic stem cell transplantation in adult patients with chronic myelomonocytic leukaemia
    Zhang, Tingting
    Liu, Xin
    Fei, Hairong
    Zhang, Lining
    Ma, Runzhi
    Shen, Yuyan
    Pang, Aiming
    Yang, Donglin
    Chen, Xin
    Zhang, Rongli
    Wei, Jialin
    He, Yi
    Jiang, Erlie
    Han, Mingzhe
    Feng, Sizhou
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (02) : 256 - 260
  • [48] A child with juvenile myelomonocytic leukaemia and monosomy 7 treated with allogeneic haematopoietic stem cell transplantation and all-trans retinoic acid
    Gursel, O.
    Kurekci, A. E.
    Altun, D.
    Atay, A. A.
    Bahce, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S154 - S155
  • [49] Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation
    Kreiter, S
    Winkelmann, N
    Schneider, PM
    Schuler, M
    Fischer, T
    Ullmann, AJ
    Huber, C
    Derigs, HG
    Kolbe, K
    BONE MARROW TRANSPLANTATION, 2001, 28 (02) : 157 - 161
  • [50] Treosulfan/fludarabine - a low toxicity but myeloablative conditioning for allogeneic hematopoietic stem cell transplantation
    Holowiecki, J
    Giebel, S
    Wojnar, J
    Krawczyk-Kulis, M
    Wylezol, I
    Kruzel, T
    Markiewicz, M
    BLOOD, 2004, 104 (11) : 292A - 292A
12345